Skip to Content

Erika C. Szabo, MPH, MsPHARM

Global Market Access Strategy Lead, Pharmaceutical Diagnostics, GE Healthcare

Erika is passionate about how to define and quantify value in healthcare. Her focus has been to ensure population decision makers have scientifically rigorous data to make informed decisions that are clinically meaningful and economically relevant.

She holds a Master’s of Science in Pharmacy (MsPHARM) from the University of Florida, a Master’s in Public Health (MPH) from the University of Michigan; a Bachelor of Arts (BA) in Economics and Political Science from Allegheny College and finishing her MBA. Her work in HEOR has yielded peer reviewed publications in several languages.

Over 20 years in Pharma her focus has been in global Health Economics and Outcomes Research (HEOR) positions for: Parke-Davis; Eli Lilly; Pfizer; Teva; Akebia and GE Healthcare. In her current GE role she leads Global Market Access Strategy. In addition she is an active member of Patient Centered Outcomes Research Institute (PCORI) as an Ambassador, Merit Reviewer and Presenter.